EP0055239A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Novel derivatives of guanine
Assignee: Astra Lakemedel AB
•
Filing: 1981-12-22
•
Granted: —
•
Expires: 2001-12-22
Abstract
Abstract Novel derivatives of guanine, viz. antiviral compounds of the formula wherein each of R 1 and R 2 , which are the same or different is hydrogen, hydroxy or fluoro; provided that R, or R 2 is hydrogen when R 1 and R 2 are different, and provided that R, and R 2 are hydroxy or fluoro when R, and R 2 are the same; or a physiologically acceptable salt of an optical isomer thereof, methods for their preparation, pharmaceutical preparations containing the compounds, and methods for the treatment of virus infections and other diseases causes by viruses.
Inventors
- 👤 Curt-Erik Hagberg
- 👤 Karl Nils-Gunnar Johansson
- 👤 Zsuzsanna Maria Ilona Kovacs
- 👤 Göran Bertil Stening
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-31 15:00
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/02; C07D307/26; C07D307/30; C07D307/32; C07D307/33; A; A61; A61P; A61P31/00; A61P31/12; C07D473/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
1480 words
A method for the preparation of a compound of the formula wherein each of R 1 and R 2 , which are the same or different, is hydrogen, hydroxy or fluoro: provided that R 1 or R 2 is hydrogen when R 1 and R 2 are different, and provided that R 1 and R 2 are hydroxy or fluoro when R 1 and R 2 are the same; or a physiologically acceptable salt or an optical isomer, comprising: A. Reducing a compound of the formula wherein R 1 and R 2 have the meaning given above, and wherein R is hydrogen, alkyl containing 1-8 carbon atoms, substituted or unsubstituted phenyl, or benzyl; B. Hydrolysing a compound of the formula wherein R 1 and R 2 have the meaning given above,X 1 is a leaving group such as chlorine, bromine, iodine or a group -SH, -OR 2 , -SR 2 or -SO 2 R 2 in which formulas R 2 is alkyl containing 1-8 carbon atoms, fluorinated alkyl containi.ng 1-8 carbon atoms, alkylaryl such as benzyl, or aryl; Cl.Hydrolysing a compound of the formula wherein Y is OH or a group X 1 as defined in method B, and R 3 , R4, R 5 and R 6 are the same or different and are hydrogen, -COR 2 , or -SO 2 R 2 wherein R 2 is as defined in method B; C2. Hydrolysing a compound of the formula IV in method Cl wherein additionally R 3 and R 4 together, or R 3 and R 5 together form a cyclic ketal as defined in method L 3 or a cyclic carbonate ester. D. Hydrolysing a compound of the formula wherein Y and R 6 are as defined in method C and Z 1 , Z 2 and Z 3 are the same or different and are halogen such as chlorine, bromine or iodine, or groups OR 3 , OR 4 or OR 5 as defined in method Cl or in method C2; to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is hydroxy; E. Hydrolysing a compound of the formula wherein R 7 is a silyloxy group such as trimethylsilyloxy or tert.-butyldiphenylsilyloxy or a group Y as defined in method C1, and R 8 , R 9 , and R 10 are the same or different and are silyl groups such as trimethylsilyloxy or tert.- butyldiphenylsilyloxy or groups Z 1 ,Z 2 and Z 3 respectively as defined in method D; and R 11 is a silyl group such as trimethylsilyl or tert.-butyldiphenylsilyl or a group R 6 as defined in method C. F. Ring-closure of a compound of the formula wherein R 7 , R 8 , R 9 , R 10 and R 11 are as defined in method E, by reaction with formic acid or a derivate thereof such as an arthoformate ester, followed by hydrolysis of the groups R 7 -R 11 as described in method E; G. Condensation of a compound of the formula with a compound of the formula wherein R 7 -R 11 are as defined in method E and X 2 is a leaving group such as chlorine, bromine, iodine or a group SO 2 R 2 where R 2 is as defined in method B, followed by hydrolysis of the groups R 7 -R 11 as described in method E; H. Vicinal dihydroxylation of the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; I. Hydrolysing the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; K. Condensation of a compound of the formula with a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 , R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 is hydroxy and R 2 is hydrogen. L. Condensation of a compound of the formula in which formulas R 1 is as defined in method A, R 12 is alkoxy containing 1-8 carbon atoms or R l ; R 7 and R 11 are as defined in method E and X 2 is as defined in method G, to the formation of a compound of the formula I wherein R 1 or R 2 is hydroxy; or a derivative thereof which can be transformed to said compound according to methods known per se; N. Reduction of a compound of the formula wherein R 1 is as defined in method A, to the formation of a compound of the formula I wherein either R 1 or R 2 is hydroxy; N. Hydroboration of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a mixture of the compounds of the formula I wherein either R 1 or R 2 is hydroxy; 0. Reduction of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; P. Fluorination of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine, or a derivative thereof which can be transformed to said compound according to methods known per se; R. Substitution of leaving groups Z 1 and/or Z 2 with fluorine in a compound of the formula wherein Z 1 and Z 2 are as defined in method D, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; S. Addition with fluorinating reagents to the isolated double bond in the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 , R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; T. Hydroboration of a compound of the formula wherein R 7 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 and R 11 as described in method E, to the formation of a compound of the formula wherein R 1 is fluorine and R 2 is hydrogen; U. Substitution of amino for X 3 in a compound of the formula wherein R 1 and R 2 have the meaning given above and X 3 is a leaving group such as chlorine, bromine or iodine, to the formation of a compound of the formula I; V. Transformation of a compound of the formula wherein R 1 and R 2 have the meaning given above and R 10 is as defined in method E, followed by hydrolysis of the group R 10 as described in method E, to the formation of a compound of the formula I; W. Ring-closure of a compound of the formula wherein R 8 , R 9 and R 10 are as defined in method E, followed by hydrolysis of the groups R 8 , R 9 and R 10 as described in method E, to the formation of a compound of the formula I. X. Hydrplysing a compound of the formula wherein R 4 is as defined in method Cl and R 7 and R 11 are as defined in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; whereupon optionally a base obtained is converted to a pharmaceutically acceptable salt or a salt obtained is converted to the base or to a different, pharmaceutically acceptable salt, and optionally an isomeric mixture obtained is separated to a pure enantiomeric isomer.
Claim 2
Independent Claim
1480 words
A method for the preparation of a compound of the formula wherein each of R 1 and R 2 , which are the same or different, is hydrogen, hydroxy or fluoro: provided that R 1 or R 2 is hydrogen when R 1 and R 2 are different, and provided that R 1 and R 2 are hydroxy or fluoro when R 1 and R 2 are the same; or a physiologically acceptable salt or an optical isomer, comprising: A. Reducing a compound of the formula wherein R 1 and R 2 have the meaning given above, and wherein R is hydrogen, alkyl containing 1-8 carbon atoms, substituted or unsubstituted phenyl, or benzyl; B. Hydrolysing a compound of the formula wherein R 1 and R 2 have the meaning given above,X 1 is a leaving group such as chlorine, bromine, iodine or a group -SH, -OR 2 , -SR 2 or -SO 2 R 2 in which formulas R 2 is alkyl containing 1-8 carbon atoms, fluorinated alkyl containi.ng 1-8 carbon atoms, alkylaryl such as benzyl, or aryl; Cl.Hydrolysing a compound of the formula wherein Y is OH or a group X 1 as defined in method B, and R 3 , R4, R 5 and R 6 are the same or different and are hydrogen, -COR 2 , or -SO 2 R 2 wherein R 2 is as defined in method B; C2. Hydrolysing a compound of the formula IV in method Cl wherein additionally R 3 and R 4 together, or R 3 and R 5 together form a cyclic ketal as defined in method L 3 or a cyclic carbonate ester. D. Hydrolysing a compound of the formula wherein Y and R 6 are as defined in method C and Z 1 , Z 2 and Z 3 are the same or different and are halogen such as chlorine, bromine or iodine, or groups OR 3 , OR 4 or OR 5 as defined in method Cl or in method C2; to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is hydroxy; E. Hydrolysing a compound of the formula wherein R 7 is a silyloxy group such as trimethylsilyloxy or tert.-butyldiphenylsilyloxy or a group Y as defined in method C1, and R 8 , R 9 , and R 10 are the same or different and are silyl groups such as trimethylsilyloxy or tert.- butyldiphenylsilyloxy or groups Z 1 ,Z 2 and Z 3 respectively as defined in method D; and R 11 is a silyl group such as trimethylsilyl or tert.-butyldiphenylsilyl or a group R 6 as defined in method C. F. Ring-closure of a compound of the formula wherein R 7 , R 8 , R 9 , R 10 and R 11 are as defined in method E, by reaction with formic acid or a derivate thereof such as an arthoformate ester, followed by hydrolysis of the groups R 7 -R 11 as described in method E; G. Condensation of a compound of the formula with a compound of the formula wherein R 7 -R 11 are as defined in method E and X 2 is a leaving group such as chlorine, bromine, iodine or a group SO 2 R 2 where R 2 is as defined in method B, followed by hydrolysis of the groups R 7 -R 11 as described in method E; H. Vicinal dihydroxylation of the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; I. Hydrolysing the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; K. Condensation of a compound of the formula with a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 , R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein R 1 is hydroxy and R 2 is hydrogen. L. Condensation of a compound of the formula in which formulas R 1 is as defined in method A, R 12 is alkoxy containing 1-8 carbon atoms or R l ; R 7 and R 11 are as defined in method E and X 2 is as defined in method G, to the formation of a compound of the formula I wherein R 1 or R 2 is hydroxy; or a derivative thereof which can be transformed to said compound according to methods known per se; N. Reduction of a compound of the formula wherein R 1 is as defined in method A, to the formation of a compound of the formula I wherein either R 1 or R 2 is hydroxy; N. Hydroboration of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a mixture of the compounds of the formula I wherein either R 1 or R 2 is hydroxy; 0. Reduction of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 ,R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; P. Fluorination of a compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine, or a derivative thereof which can be transformed to said compound according to methods known per se; R. Substitution of leaving groups Z 1 and/or Z 2 with fluorine in a compound of the formula wherein Z 1 and Z 2 are as defined in method D, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; S. Addition with fluorinating reagents to the isolated double bond in the compound of the formula wherein R 7 , R 10 and R 11 are as defined in method E, followed by hydrolysis of the groups R 7 , R 10 and R 11 as described in method E, to the formation of a compound of the formula I wherein at least one of R 1 and R 2 is fluorine; T. Hydroboration of a compound of the formula wherein R 7 and R 11 are as defined in method E,followed by hydrolysis of the groups R 7 and R 11 as described in method E, to the formation of a compound of the formula wherein R 1 is fluorine and R 2 is hydrogen; U. Substitution of amino for X 3 in a compound of the formula wherein R 1 and R 2 have the meaning given above and X 3 is a leaving group such as chlorine, bromine or iodine, to the formation of a compound of the formula I; V. Transformation of a compound of the formula wherein R 1 and R 2 have the meaning given above and R 10 is as defined in method E, followed by hydrolysis of the group R 10 as described in method E, to the formation of a compound of the formula I; W. Ring-closure of a compound of the formula wherein R 8 , R 9 and R 10 are as defined in method E, followed by hydrolysis of the groups R 8 , R 9 and R 10 as described in method E, to the formation of a compound of the formula I. X. Hydrplysing a compound of the formula wherein R 4 is as defined in method Cl and R 7 and R 11 are as defined in method E, to the formation of a compound of the formula I wherein R 1 and R 2 are hydroxy; whereupon optionally a base obtained is converted to a pharmaceutically acceptable salt or a salt obtained is converted to the base or to a different, pharmaceutically acceptable salt, and optionally an isomeric mixture obtained is separated to a pure enantiomeric isomer.
Claim 3
Dependent Claim
13 words
A method according to claim 1 for the preparation of the compound 9-(3,4-dihydroxybutyl)guanine.
Claim 4
Independent Claim
12 words
A method according to claim'l for the preparation of the compound 9-(2,4-dihydroxybutyl)guanine.
Claim 5
Dependent Claim
20 words
A method according to claim 1 for the preparation of the compound 9-(2,3,4-trihydroxybutyl)guanine, optionally as the erythro or threo form.
Claim 6
Dependent Claim
13 words
A method according to claim 1 for the preparation of the compound 9-(3-fluoro-4-hydroxybutyl)guanine.
Claim 7
Dependent Claim
13 words
A method according to claim 1 for the preparation of the compound 9-(2-fluoro-4-hydroxybutyl)guanine.
Claim 8
Dependent Claim
20 words
A method according to claim 1 for the preparation of the compound 9-(2,3-difluoro-4-hydroxybutyl)guanine, optionally as the erythro or threo form.
Claim 9
Independent Claim
21 words
A method according to one of claims 1,2,3,4,5,6 or 7 for the preparation of an optical isomer of the final product.
Claim 10
Independent Claim
22 words
A method according to one of claims 1,2,3,4,5,6 or 7 for the preparation of a physiologically acceptable salt of the final product.
Claim 11
Dependent Claim
88 words
The use of a compound of the formula wherein each of R 1 and R 2 , which are the same or different, is hydrogen, hydroxy or fluoro; provided that R 1 or R 2 is hydrogen when R 1 and R 2 are different, and provided that R 1 and R 2 are hydroxy or fluoro when R 1 and R 2 are the same; or a physiologically acceptable salt or an optical isomer thereof, as active ingredient for the preparation of pharmaceutical compositions having antiviral activity.
Claim 12
Dependent Claim
88 words
The use of a compound of the formula wherein each of R 1 and R 2 , which are the same or different, is hydrogen, hydroxy or fluoro; provided that R 1 or R 2 is hydrogen when R 1 and R 2 are different, and provided that R 1 and R 2 are hydroxy or fluoro when R 1 and R 2 are the same; or a physiologically acceptable salt or an optical isomer thereof, as active ingredient for the preparation of pharmaceutical compositions having antiviral activity.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.